Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which was invested in and incubated by Viva Biotech Holdings....
Sagard Announces Strategic Partnership with BEX Capital to Strengthen Private Equity Secondaries Offering
Following this strategic partnership with a secondaries platform, Sagard now offers a full suite of private equity solutions and expands its global investment footprint MONTREAL and NICE, France, April 16, 2025 /PRNewswire/ -- Sagard, a global...